In stock
Ranolazine was developed to protect the heart from transient ischemia, as may occur during angina and infarct. It has diverse effects at the cellular level, inhibiting late sodium and potassium currents and blocking ligand binding to α1, β1, and β2 adrenergic receptors.
C24H35N3O4•2HCl
BIOLEAF熱搜 BIOLEAF試劑盒 BIOLEAF ELISA BIOLEAF試劑 BIOLEAF品牌 BIOLEAF抗體 BIOLEAF耗材 BIOLEAF小儀器
sitemap 細胞庫查詢 危險品圖標 本公司網站所展示銷售的產品僅供科研！
滬公網安備 31011202007338號